substance p (5-11), pglu(5)-mephe(8)-megly(9)- has been researched along with methoxamine in 1 studies
| Studies (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Trials (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Recent Studies (post-2010) (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Studies (methoxamine) | Trials (methoxamine) | Recent Studies (post-2010) (methoxamine) |
|---|---|---|---|---|---|
| 47 | 0 | 0 | 2,135 | 57 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catanzariti, R; van Den Buuse, M | 1 |
1 other study(ies) available for substance p (5-11), pglu(5)-mephe(8)-megly(9)- and methoxamine
| Article | Year |
|---|---|
Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Male; Methoxamine; Microinjections; Neurotensin; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Stimulation, Chemical; Substance P; Vasoconstrictor Agents; Vasopressins; Ventral Tegmental Area | 2000 |